Accessibility StatementSkip Navigation LANCASTER, Calif., Sept. 16, 2025 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE American: LGCY), a leading provider of career education healthcare programs, announces the appointment of Zwade J. Marshall, MD, MBA and Janis L. Paulson to its Board of Directors. These individuals bring significant experience in clinical medicine, financial innovation, and higher education leadership, further strengthening Legacy's ability to expand ac ...

Financial Data and Key Metrics Changes - Revenue for Q3 fiscal 2025 reached $18.6 million, a 50.7% increase from $12.3 million in Q3 fiscal 2024, driven by a 70.7% increase in new student starts and a 49.8% growth in ending enrollment to 3,245 students [6][10] - Net income increased by 57.1% to $2.8 million or $0.21 per diluted share compared to $1.8 million or $0.19 per diluted share in Q3 fiscal 2024 [11] - Adjusted EBITDA rose 60% to $3.9 million from $2.4 million last year, reflecting strong operational execution [9][12] Business Line Data and Key Metrics Changes - Educational services accounted for $10.1 million or 54.4% of revenue, up from $6.5 million or 53.1% in Q3 fiscal 2024, indicating investment in instructional staff and program support [11] - Marketing expenses increased to $1.2 million from $900,000, supporting student acquisition efforts [12] Market Data and Key Metrics Changes - The overall nursing NCLEX pass rate is 83%, with an average placement rate of 75.6% through the accreditor ABHES, underscoring the quality of education and success of graduates [7] - Enrollment trends are strong across all six campuses located in areas with robust job growth [9] Company Strategy and Development Direction - The company aims to drive enrollment growth, expand program offerings, optimize operational efficiency, and pursue branching and accretive acquisitions [14][16] - New programs are being added in high-demand fields such as sterile processing and surgical technician, aligning with employer needs [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued momentum, citing strong demand for healthcare professionals and the successful integration of Contra Costa Medical Career College [16][17] - The company is well-positioned to navigate regulatory dynamics and maintain relevance in the market due to its focus on high-demand allied health careers [16] Other Important Information - The company has $17.3 million in cash and $22 million in working capital, providing ample liquidity for growth and acquisitions [9][12] - Capital expenditures for the nine months were $800,000, primarily for campus enhancements and technology upgrades [12] Q&A Session Summary Question: What drove the quarter's outperformance? - Management noted strong performance in medical assisting, nursing, cardiac, and imaging programs, with additional nursing and imaging classes contributing significantly [19][20] Question: What does the acquisition pipeline look like? - Management confirmed ongoing discussions regarding potential acquisitions but did not disclose specific details [26] Question: How should Q4 be framed in light of seasonality? - Management indicated that Q4 is expected to show similar seasonality to previous years, with some starts from Q2 impacting Q3 results [31][32] Question: Can you provide details on the EMT program? - The EMT program is currently approved at HDMC locations, with plans to roll it out to additional campuses pending state and county approvals [34][35] Question: Any updates on neurology programs? - Management stated that while research is ongoing, there are currently no neurology programs offered [36]